Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02328677 · ClinicalTrials.gov registry record
ColoCare Study - Colorectal Cancer Cohort
A clinical trial of Colorectal Cancer, sponsored by University of Utah.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 7
- Study locations
NCT02328677: Recruiting study of Colorectal Cancer, sponsored by University of Utah.
NCT02328677 is a study of Colorectal Cancer that is actively recruiting participants, run by University of Utah. The registered enrollment target is 5,000 participants, above the 1,532-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (226% higher). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02328677, a study of Colorectal Cancer, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).
Conditions Studied
Study Locations (7)
California
- Cedars-Sinai Medical Center - Los Angeles
Florida
- Lee H. Moffitt Cancer Center - Tampa
Missouri
- Washington University School of Medicine - St Louis
Tennessee
- University of Tennessee - Knoxville
Utah
- Huntsman Cancer Institute - Salt Lake City
Washington
- FHCRC - Seattle
Baden-Wurttemberg
- University Hospital Heidelberg - Heidelberg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2007-03 |
| Est. Completion | 2030-10 |
What NCT02328677 shows while recruiting
NCT02328677 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,532-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (226% higher).
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT02328677 lists 7 locations in 7 states (California, Florida, Missouri).
Frequently Asked Questions
What is clinical trial NCT02328677 about?
NCT02328677 is a clinical study titled "ColoCare Study - Colorectal Cancer Cohort". ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).
What is the current status of trial NCT02328677?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2007-03. Estimated completion is 2030-10.
What conditions does trial NCT02328677 study?
This clinical trial studies the following conditions: Colorectal Cancer.
Who is sponsoring clinical trial NCT02328677?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02328677 being conducted?
This trial has 7 study locations across California, Florida, Missouri, Tennessee, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02328677's enrollment target sits among peer trials
5,000 18th of 381 higher than 362 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia